Plain Votes

U.S. House · 118th Congress · H.R. 6227

Adding Coccidioidomycosis to the FDA Priority Review Voucher Program Act of 2023

To amend the Federal Food, Drug, and Cosmetic Act to expand the tropical disease product priority review voucher program to encourage prevention and treatment of coccidioidomycosis.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
David SchweikertR-AZ-1
Introduced
November 3, 2023, in the House
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (35)

21 Republicans, 14 Democrats. Each member is shown with the party they were counted with on the day they signed on. How we count these

Original cosponsors

Signed on later